• +1 855 222-4111
  • contact@pressreleasepower.com

WHO backs Paxlovid for high-risk COVID patients

Leave a Comment / Covid 19 / By

Also, the WHO revised its assessment of remdesivir, recommending it for mild or moderate infections in high-risk groups.

source
News Wire

Leave a Comment

Your email address will not be published.

Press Release Power (PRP) is the Best Premium Press Release Distribution platform that helps clients increase their online visibility and web presence. It comprises amazing press release distribution packages for the press release.

Facebook-f Tumblr Twitter Pinterest Youtube Linkedin-in Linkedin-in

Get in Touch!

  • Press Release Power New York, USA
  • +1 855 222-4111
  • contact@pressreleasepower.com

Trending News

About

  • The Ultimate Guide on How to Distribute a Press Release
  • Sample Press Release Format - PR Writing
  • Distribution
  • WSJ News Fact Sheet
  • Sky News Worldwide News Channel Fact Sheet
  • Top 10 National newspapers in Germany
  • Top 10 U.K. Newspapers
  • Top 10 journalists in Sao Paulo
  • Top Free PR Press Release Submission Sites
  • Press Release FAQ
  • All Tips & Guide
  • All Press Release
  • All Video Press Release
  • Unlimited Press Releases
  • All Sitemap
  • Regional Press Release
  • Industry Press Release
  • Journalist
  • Journalist Directory
  • Trending News
 2021 © Copyright All Rights Reserved. Perfect Marketing Solution.
Terms   Privacy